Shares of Advanced Oncotherapy plc (LON:AVO – Get Free Report) passed above its fifty day moving average during trading on Monday . The stock has a fifty day moving average of GBX 1.75 ($0.02) and traded as high as GBX 1.75 ($0.02). Advanced Oncotherapy shares last traded at GBX 1.75 ($0.02), with a volume of 200,000 shares trading hands.
Advanced Oncotherapy Stock Performance
The stock’s fifty day simple moving average is GBX 1.75 and its 200 day simple moving average is GBX 1.75. The company has a market cap of £9.49 million, a price-to-earnings ratio of -25.00 and a beta of 0.06. The company has a current ratio of 1.26, a quick ratio of 0.13 and a debt-to-equity ratio of 98.71.
About Advanced Oncotherapy
Advanced Oncotherapy plc, together with its subsidiaries, engages in designing, assembling, and selling proton-based radiotherapy systems for treatment of cancer. It is developing Linac Image Guided Hadron Technology, a proton therapy system for treating cancer. The company also engages in the management of healthcare related properties.
Read More
- Five stocks we like better than Advanced Oncotherapy
- How to Invest in Blue Chip Stocks
- Is Monolithic Power Systems a Screaming Buy After Near 40% Drop?
- Best Stocks Under $10.00
- Applied Materials Market Capitulates: Now is the Time to Buy
- Election Stocks: How Elections Affect the Stock Market
- 3 Ultra-High Dividend Yield Stocks for the New Year
Receive News & Ratings for Advanced Oncotherapy Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Advanced Oncotherapy and related companies with MarketBeat.com's FREE daily email newsletter.
